BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32901907)

  • 1. Combined expression levels of KDM2A and KDM2B correlate with nucleolar size and prognosis in primary breast carcinomas.
    De Nicola I; Guerrieri AN; Penzo M; Ceccarelli C; De Leo A; Trerè D; Montanaro L
    Histol Histopathol; 2020 Oct; 35(10):1181-1187. PubMed ID: 32901907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. JHDM1B expression regulates ribosome biogenesis and cancer cell growth in a p53 dependent manner.
    Penzo M; Casoli L; Pollutri D; Sicuro L; Ceccarelli C; Santini D; Taffurelli M; Govoni M; Brina D; Trerè D; Montanaro L
    Int J Cancer; 2015 Mar; 136(5):E272-81. PubMed ID: 25273595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative isoforms of KDM2A and KDM2B lysine demethylases negatively regulate canonical Wnt signaling.
    Lađinović D; Pinkas D; Šopin T; Raška O; Liška F; Raška I; Vacík T
    PLoS One; 2020; 15(10):e0236612. PubMed ID: 33104714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated genomic and functional analyses of histone demethylases identify oncogenic KDM2A isoform in breast cancer.
    Liu H; Liu L; Holowatyj A; Jiang Y; Yang ZQ
    Mol Carcinog; 2016 May; 55(5):977-90. PubMed ID: 26207617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
    Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
    Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic up-regulation of ribosome biogenesis and more aggressive phenotype triggered by the lack of the histone demethylase JHDM1B in mammary epithelial cells.
    Galbiati A; Penzo M; Bacalini MG; Onofrillo C; Guerrieri AN; Garagnani P; Franceschi C; Treré D; Montanaro L
    Oncotarget; 2017 Jun; 8(23):37091-37103. PubMed ID: 28415746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammalian lysine histone demethylase KDM2A regulates E2F1-mediated gene transcription in breast cancer cells.
    Rizwani W; Schaal C; Kunigal S; Coppola D; Chellappan S
    PLoS One; 2014; 9(7):e100888. PubMed ID: 25029110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depletion of histone demethylase KDM2A inhibited cell proliferation of stem cells from apical papilla by de-repression of p15INK4B and p27Kip1.
    Gao R; Dong R; Du J; Ma P; Wang S; Fan Z
    Mol Cell Biochem; 2013 Jul; 379(1-2):115-22. PubMed ID: 23559091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay between the Epigenetic Enzyme Lysine (K)-Specific Demethylase 2B and Epstein-Barr Virus Infection.
    Vargas-Ayala RC; Jay A; Manara F; Maroui MA; Hernandez-Vargas H; Diederichs A; Robitaille A; Sirand C; Ceraolo MG; Romero-Medina MC; Cros MP; Cuenin C; Durand G; Le Calvez-Kelm F; Mundo L; Leoncini L; Manet E; Herceg Z; Gruffat H; Accardi R
    J Virol; 2019 Jul; 93(13):. PubMed ID: 30996097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysine demethylase 2A promotes stemness and angiogenesis of breast cancer by upregulating Jagged1.
    Chen JY; Li CF; Chu PY; Lai YS; Chen CH; Jiang SS; Hou MF; Hung WC
    Oncotarget; 2016 May; 7(19):27689-710. PubMed ID: 27029061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone demethylase KDM2B promotes triple negative breast cancer proliferation by suppressing p15INK4B, p16INK4A, and p57KIP2 transcription.
    Zheng Q; Fan H; Meng Z; Yuan L; Liu C; Peng Y; Zhao W; Wang L; Li J; Feng J
    Acta Biochim Biophys Sin (Shanghai); 2018 Sep; 50(9):897-904. PubMed ID: 30060056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The histone demethylase KDM2B activates FAK and PI3K that control tumor cell motility.
    Zacharopoulou N; Kallergi G; Alkahtani S; Tsapara A; Alarifi S; Schmid E; Sukkar B; Kampranis S; Lang F; Stournaras C
    Cancer Biol Ther; 2020 Jun; 21(6):533-540. PubMed ID: 32175798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional repression of histone deacetylase 3 by the histone demethylase KDM2A is coupled to tumorigenicity of lung cancer cells.
    Dhar SS; Alam H; Li N; Wagner KW; Chung J; Ahn YW; Lee MG
    J Biol Chem; 2014 Mar; 289(11):7483-96. PubMed ID: 24482232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression pattern and regulatory effect of lysine-specific demethylase 2A gene in clear cell renal cell carcinoma.
    Wang J; Li T; Li X; Zhang Y; Wang X
    BMC Urol; 2021 Aug; 21(1):108. PubMed ID: 34391411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional regulation of amino acid metabolism by KDM2B, in the context of ncPRC1.1 and in concert with MYC and ATF4.
    Chavdoula E; Anastas V; La Ferlita A; Aldana J; Carota G; Spampinato M; Soysal B; Cosentini I; Parashar S; Sircar A; Nigita G; Sehgal L; Freitas MA; Tsichlis PN
    Metabolism; 2024 Jan; 150():155719. PubMed ID: 37935302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CxxC-ZF domain is needed for KDM2A to demethylate histone in rDNA promoter in response to starvation.
    Tanaka Y; Umata T; Okamoto K; Obuse C; Tsuneoka M
    Cell Struct Funct; 2014; 39(1):79-92. PubMed ID: 24553073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone demethylase KDM2A suppresses EGF-TSPAN8 pathway to inhibit breast cancer cell migration and invasion in vitro.
    Zhang H; Tu Y; Huang B; Xiao J; Xiao J; Wang J; Pei Y; Yang R; Feng J; Li J; Zhang X
    Biochem Biophys Res Commun; 2022 Nov; 628():104-109. PubMed ID: 36084547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A CxxC domain that binds to unmethylated CpG is required for KDM2A to control rDNA transcription].
    Tsuneoka M; Tanaka Y; Okamoto K
    Yakugaku Zasshi; 2015; 135(1):11-21. PubMed ID: 25743893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The epigenetic factor KDM2B regulates cell adhesion, small rho GTPases, actin cytoskeleton and migration in prostate cancer cells.
    Zacharopoulou N; Tsapara A; Kallergi G; Schmid E; Tsichlis PN; Kampranis SC; Stournaras C
    Biochim Biophys Acta Mol Cell Res; 2018 Apr; 1865(4):587-597. PubMed ID: 29408056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KDM2B is involved in the epigenetic regulation of TGF-β-induced epithelial-mesenchymal transition in lung and pancreatic cancer cell lines.
    Wanna-Udom S; Terashima M; Suphakhong K; Ishimura A; Takino T; Suzuki T
    J Biol Chem; 2021; 296():100213. PubMed ID: 33779563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.